FDA Grants Priority Review to Idebenone for Leber Hereditary Optic Neuropathy
A rare disease, a rare chance. FDA fast-tracks idebenone for LHON. The U.S. Food and Drug Administration (FDA) doesn’t hand…
Day 3 at EURETINA 2025: Gene Therapy, Keynote Lectures Galore, Industry Updates and More
We bring our EURETINA 2025 coverage out with a bang on Day 3 with inherited retinal disease updates, keynote lectures…
popular posts
latest posts